Skip to content
Search jobs inside your AI agent. Claude, ChatGPT, Claude Code, Codex, Gemini, Cursor and Grok
Connect

Lexeo Therapeutics

Develops genetic medicines for cardiovascular and neurodegenerative diseases.

H-1B sponsor history — This employer has had H-1B petitions approved by USCIS in the last five fiscal years, per the USCIS H-1B Employer Data Hub. The approval belongs to the employer and is not a commitment to sponsor this role.
biotechhealthcarepharmaceuticals

Correct Lexeo Therapeutics

Lexeo Therapeutics is…

Company facts

Founded
2017
Employees
85
Headquarters
United States
Type
Public
Listed
NASDAQ: LXEO

About

Based in New York City, Lexeo Therapeutics is a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Building on groundbreaking research from Weill Cornell Medicine and the University of California San Diego, Lexeo partners with preeminent institutions on the cutting edge of gene therapy research. Our approach prioritizes high-impact genetic medicine candidates for cardiovascular diseases and APOE4-associated Alzheimer’s disease. By leveraging early proof-of-concept data, we are committed to efficient development and advanced manufacturing to address the underlying genetic causes of devastating diseases. Our pipeline includes investigational AAV-mediated gene therapies in both cardiovascular conditions and conditions of the central nervous system (CNS). We aim to create substantial positive impacts and reduce the burdens placed on patients and healthcare systems. Lexeo's management team comprises pioneers and driven leaders with decades of experience in gene therapy and rare diseases. We remain focused on employing strategic partnerships and collaborations to push the boundaries of gene therapy and offer potential cures for complex genetic disorders. With an FDA-granted Fast Track designation for our therapies, we are poised to advance clinical trials that could change the lives of the patients we serve.

Open positions

3 jobs

Scientist I/II, Modality Engineering

Open 21d 4 weeks agoFull-timeJunior2 questions 111K – 150K $
On-site
United States
New York, New York

Role Summary Lexeo is hiring a hands-on Modality Engineering Scientist to design, synthesize, and characterize oligonucleotides, bioconjugates, and AAV therapeutics for our discovery pipeline. The scientist will…

Lever

Scientist I/II, In Vivo Pharmacology

Open 21d 4 weeks agoFull-timeJunior2 questions 111K – 150K $
On-site
United States
New York, New York

Role Summary Lexeo is seeking a hands-on in vivo pharmacologist to build rodent models of cardiac disease and use them to de-risk targets, screen therapeutic candidates and advance our discovery pipeline. The scientist…

Lever

Lab Operations Associate Scientist/Scientist I (Contract)

Open 156d 6 months ago20 viewsContractJunior2 questions
On-site
United States
New York, New York

Role Summary We are looking for a talented and highly motivated contract Lab Operations Associate Scientist/Scientist I to join the Lexeo Team in NYC to support the operations within our gene therapy laboratory. You…

Lever